|
FY2025
12 months to Dec 27, 2025
|
FY2024
12 months to Dec 28, 2024
|
FY2023
3 months to Mar 31, 2024
|
FY2022
1 months to Jan 27, 2023
|
FY2021
12 months to Dec 25, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Non-cash (gain) loss on equity investments | |||||
| Gain on sale of equity investment | |||||
| Gain on deconsolidation of subsidiary | |||||
| Income taxes | |||||
| Foreign currency gains | |||||
| Loss on disposal of property and equipment | |||||
| Provision for credit losses | |||||
| Noncash provision for excess inventory | |||||
| Accrued litigation damages | |||||
| Changes in other non-cash items | |||||
| Changes in assets and liabilities, net of deconsolidation of subsidiary: | |||||
| Accounts receivable | |||||
| Contract assets | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Accrued warranty | |||||
| Contract liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from sale of marketable securities | |||||
| Proceeds from sale of equity investment | |||||
| Other assets | |||||
| Capital expenditures | |||||
| Deconsolidation of subsidiary cash | |||||
| Payments to equity method investee | |||||
| Purchases of marketable securities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Issuance of common stock, net of costs | |||||
| Issuance of common stock and pre-funded warrants, net of costs | |||||
| Issuance of preferred stock, net of costs | |||||
| Settlements of restricted stock for tax withholding obligations | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Construction in progress included in accrued expenses | |||||
| Right-of-use asset obtained in exchange for lease liability | |||||
| Accrued dividends | |||||
Loading...